miR-22 as a prognostic factor targets glucose transporter protein type 1 in breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

miR-22 as a prognostic factor targets glucose transporter protein type 1 in breast cancer

Published:2015-01 Issue:2 Volume:356 Page:410-417
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Chen Bo,Tang Hailin,Liu Xiaoping,Liu Peng,Yang Lu,Xie Xinhua,Ye Feng,Song Cailu,Xie Xiaoming,Wei Weidong

Funder

National Natural Science Foundation of China

Key Program of National Natural Science Foundation of China

China Postdoctoral Science Foundation

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference24 articles.

1. Cancer statistics, 2013;Siegel;CA Cancer J. Clin,2013

2. Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelines;Carlson;J. Natl. Compr. Canc. Netw,2012

3. MicroRNAs: target recognition and regulatory functions;Bartel;Cell,2009

4. MicroRNAs: cobblestones on the road to cancer metastasis;Profumo;Crit. Rev. Oncog,2013

5. miRNAs as modulators of angiogenesis;Landskroner-Eiger;Cold Spring Harb. Perspect. Med,2013

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptional regulation and post-translational modifications in the glycolytic pathway for targeted cancer therapy;Acta Pharmacologica Sinica;2024-04-15

2. Construction of a disulfidptosis-related glycolysis gene risk model to predict the prognosis and immune infiltration analysis of gastric adenocarcinoma;Clinical and Translational Oncology;2024-04-08

3. Trop-2 Expression and Its Impact on Survival in Thymic Epithelial Tumors: Brief Report;Clinical Lung Cancer;2024-03

4. Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer;Acta Pharmaceutica Sinica B;2023-10

5. Prognostic impact of the combination of HIF‑1α and GLUT1 in patients with oesophageal squamous cell carcinoma;Oncology Letters;2023-07-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3